Clinical Trials Browser

Phase 2/3 × INDUSTRY × Gefitinib × Clear all

NCT03653546 2025-09-10

BM

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

NCT00259064 2016-06-02

INSTEP

Phase 2/3 Completed

NSCLC

NCT00234429 2007-12-18

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms